Correlation Between China SXT and Petros Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both China SXT and Petros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China SXT and Petros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between China SXT Pharmaceuticals and Petros Pharmaceuticals, you can compare the effects of market volatilities on China SXT and Petros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China SXT with a short position of Petros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of China SXT and Petros Pharmaceuticals.

Diversification Opportunities for China SXT and Petros Pharmaceuticals

0.45

Correlation Coefficient

China SXT  Petros Pharmaceuticals

Very weak diversification

The 3 months correlation between China and Petros is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding China SXT Pharmaceuticals and Petros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Petros Pharmaceuticals and China SXT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China SXT Pharmaceuticals are associated (or correlated) with Petros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Petros Pharmaceuticals has no effect on the direction of China SXT i.e., China SXT and Petros Pharmaceuticals go up and down completely randomly.

Pair Corralation between China SXT and Petros Pharmaceuticals

Given the investment horizon of 90 days China SXT is expected to generate 4.5 times less return on investment than Petros Pharmaceuticals. But when comparing it to its historical volatility, China SXT Pharmaceuticals is 2.35 times less risky than Petros Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Petros Pharmaceuticals is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  27.00  in Petros Pharmaceuticals on October 1, 2024 and sell it today you would earn a total of  9.40  from holding Petros Pharmaceuticals or generate 34.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

China SXT Pharmaceuticals  vs.  Petros Pharmaceuticals

China SXT Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days China SXT Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Petros Pharmaceuticals

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Petros Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, Petros Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with China SXT and Petros Pharmaceuticals

The main advantage of trading using opposite China SXT and Petros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China SXT position performs unexpectedly, Petros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Petros Pharmaceuticals will offset losses from the drop in Petros Pharmaceuticals' long position.

The idea behind China SXT Pharmaceuticals and Petros Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.